T2 Biosystems PE Ratio 2013-2024 | TTOO
Current and historical p/e ratio for T2 Biosystems (TTOO) from 2013 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. T2 Biosystems PE ratio as of June 13, 2025 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| T2 Biosystems PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2025-06-13 | 0.14 | 0.00 | |
| 2024-09-30 | 1.97 | $-3.89 | 0.00 |
| 2024-06-30 | 5.34 | $-6.77 | 0.00 |
| 2024-03-31 | 3.00 | $-14.11 | 0.00 |
| 2023-12-31 | 6.28 | $-143.45 | 0.00 |
| 2023-09-30 | 22.09 | $-143.45 | 0.00 |
| 2023-06-30 | 7.06 | $-435.00 | 0.00 |
| 2023-03-31 | 46.00 | $-927.00 | 0.00 |
| 2022-12-31 | 142.00 | $-1,295.00 | 0.00 |
| 2022-09-30 | 565.00 | $-1,645.00 | 0.00 |
| 2022-06-30 | 807.50 | $-1,750.00 | 0.00 |
| 2022-03-31 | 2620.50 | $-1,650.00 | 0.00 |
| 2021-12-31 | 2581.00 | $-1,500.00 | 0.00 |
| 2021-09-30 | 4576.00 | $-1,500.00 | 0.00 |
| 2021-06-30 | 5950.00 | $-1,500.00 | 0.00 |
| 2021-03-31 | 8100.00 | $-1,550.00 | 0.00 |
| 2020-12-31 | 6200.00 | $-2,300.00 | 0.00 |
| 2020-09-30 | 6800.00 | $-3,450.00 | 0.00 |
| 2020-06-30 | 6350.00 | $-4,600.00 | 0.00 |
| 2020-03-31 | 3247.50 | $-5,900.00 | 0.00 |
| 2019-12-31 | 5850.00 | $-6,500.00 | 0.00 |
| 2019-09-30 | 12500.00 | $-6,750.00 | 0.00 |
| 2019-06-30 | 8400.00 | $-6,450.00 | 0.00 |
| 2019-03-31 | 13150.00 | $-6,300.00 | 0.00 |
| 2018-12-31 | 15050.00 | $-6,400.00 | 0.00 |
| 2018-09-30 | 37250.00 | $-4,650.00 | 0.00 |
| 2018-06-30 | 38700.00 | $-5,650.00 | 0.00 |
| 2018-03-31 | 32450.00 | $-6,550.00 | 0.00 |
| 2017-12-31 | 20600.00 | $-7,150.00 | 0.00 |
| 2017-09-30 | 21000.00 | $-9,500.00 | 0.00 |
| 2017-06-30 | 16050.00 | $-9,800.00 | 0.00 |
| 2017-03-31 | 26300.00 | $-10,200.00 | 0.00 |
| 2016-12-31 | 26300.00 | $-10,550.00 | 0.00 |
| 2016-09-30 | 36200.00 | $-11,000.00 | 0.00 |
| 2016-06-30 | 39450.00 | $-11,300.00 | 0.00 |
| 2016-03-31 | 49300.00 | $-11,100.00 | 0.00 |
| 2015-12-31 | 54700.00 | $-11,000.00 | 0.00 |
| 2015-09-30 | 43800.00 | $-10,450.00 | 0.00 |
| 2015-06-30 | 81150.00 | $-11,150.00 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.003B | $0.007B |
| T2 Biosystems, Inc. is an in vitro diagnostics company. It has developed a technology platform that is designed to offer a rapid, sensitive and simple alternative to existing diagnostic methodologies. The Company uses its T2 Magnetic Resonance platform, or T2MR, that enables rapid detection of pathogens, biomarkers and other abnormalities in a variety of unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum and urine, and can detect cellular targets. It operates primarily in the United States. T2 Biosystems, Inc. is headquartered in Lexington, Massachusetts. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Intuitive Surgical (ISRG) | United States | $183.869B | 80.53 |
| Thermo Fisher Scientific (TMO) | United States | $156.785B | 18.97 |
| Edwards Lifesciences (EW) | United States | $44.517B | 29.19 |
| Alcon (ALC) | Switzerland | $43.958B | 29.71 |
| IDEXX Laboratories (IDXX) | United States | $42.376B | 48.70 |
| DexCom (DXCM) | United States | $32.486B | 50.21 |
| IQVIA Holdings (IQV) | United States | $27.529B | 15.42 |
| Mettler-Toledo (MTD) | United States | $24.694B | 29.37 |
| STERIS (STE) | Ireland | $23.846B | 26.26 |
| Waters (WAT) | United States | $20.803B | 29.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $18.964B | 0.00 |
| Hologic (HOLX) | United States | $14.534B | 15.79 |
| Sysmex ADR (SSMXY) | Japan | $10.991B | 31.18 |
| Penumbra (PEN) | United States | $9.813B | 77.02 |
| Masimo (MASI) | United States | $8.965B | 33.07 |
| Globus Medical (GMED) | United States | $8.150B | 19.42 |
| Glaukos (GKOS) | United States | $5.577B | 0.00 |
| Teleflex (TFX) | United States | $5.395B | 8.91 |
| TransMedics (TMDX) | United States | $4.838B | 105.18 |
| Integer Holdings (ITGR) | United States | $4.143B | 21.71 |
| PROCEPT BioRobotics (PRCT) | United States | $3.384B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.543B | 15.14 |
| Nihon Kohden (NHNKY) | Japan | $2.185B | 25.06 |
| Veracyte (VCYT) | United States | $2.090B | 29.33 |
| Elekta AB (EKTAY) | Sweden | $1.972B | 17.72 |
| Alphatec Holdings (ATEC) | United States | $1.662B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.393B | 0.00 |
| Artivion (AORT) | United States | $1.227B | 114.96 |
| Pulse Biosciences (PLSE) | United States | $1.088B | 0.00 |
| OPKO Health (OPK) | United States | $1.063B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.986B | 5.24 |
| Beta Bionics (BBNX) | United States | $0.845B | 0.00 |
| SiBone (SIBN) | United States | $0.778B | 0.00 |
| IRadimed (IRMD) | United States | $0.757B | 38.43 |
| RxSight (RXST) | United States | $0.580B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.572B | 8.90 |
| Mesa Laboratories (MLAB) | United States | $0.545B | 12.77 |
| Delcath Systems (DCTH) | United States | $0.545B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.528B | 0.00 |
| AxoGen (AXGN) | United States | $0.457B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.442B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.437B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.369B | 0.00 |
| NeuroPace (NPCE) | United States | $0.368B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.354B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.343B | 9.12 |
| ClearPoint Neuro (CLPT) | United States | $0.338B | 0.00 |
| 908 Devices (MASS) | United States | $0.258B | 0.00 |
| Neuronetics (STIM) | United States | $0.251B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.231B | 14.01 |
| Sight Sciences (SGHT) | United States | $0.218B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.216B | 0.00 |
| Biosig Technologies (BSGM) | United States | $0.189B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.184B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.176B | 0.00 |
| Inogen (INGN) | United States | $0.173B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.158B | 0.00 |
| CVRx (CVRX) | United States | $0.154B | 0.00 |
| LENSAR (LNSR) | United States | $0.147B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.142B | 0.00 |
| Accuray (ARAY) | United States | $0.129B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.111B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.094B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.090B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.082B | 49.70 |
| EnVVeno Medical (NVNO) | United States | $0.077B | 0.00 |
| InspireMD (NSPR) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.066B | 0.00 |
| Hyperfine (HYPR) | United States | $0.058B | 0.00 |
| Spectral AI (MDAI) | United States | $0.054B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.052B | 0.00 |
| Precision Optics (POCI) | United States | $0.037B | 0.00 |
| DarioHealth (DRIO) | United States | $0.031B | 0.00 |
| Envoy Medical (COCH) | United States | $0.031B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.028B | 0.00 | |
| Adagio Medical Holdings (ADGM) | United States | $0.018B | 0.00 |
| NexGel (NXGL) | United States | $0.017B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.012B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.010B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.009B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.008B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.007B | 0.00 |
| Tenon Medical (TNON) | United States | $0.007B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.005B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.004B | 0.00 |
| Venus Concept (VERO) | Canada | $0.004B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.003B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.001B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.001B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 16.54 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |